Vitamin K supplementation to decrease variability of International Normalized Ratio in patients on vitamin K antagonists: A literature review

Current Opinion in Hematology

Volumn 15, Issue 5, 2008, Pages 504-508

  Ford, Sarah K ^a,b,c   Moll, Stephan ^b  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

International Normalized Ratio; Stability; Vitamin K; Warfarin

Indexed keywords

ANTIVITAMIN K; FARNOQUINONE; PHYTOMENADIONE; WARFARIN; ANTICOAGULANT AGENT; VITAMIN K GROUP;

ANAMNESIS; ANTICOAGULATION; BLEEDING; CLINICAL TRIAL; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; INTERNATIONAL NORMALIZED RATIO; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; THROMBOEMBOLISM; THROMBOSIS; THROMBOSIS PREVENTION; VITAMIN SUPPLEMENTATION; DRUG ANTAGONISM; TREATMENT OUTCOME;

ANTICOAGULANTS; DIETARY SUPPLEMENTS; HUMANS; INTERNATIONAL NORMALIZED RATIO; TREATMENT OUTCOME; VITAMIN K;

EID: 55249114199     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328304b3c5     Document Type: Review

References (17)

1. Roberts HR, Monroe DM, Hoffman M. Chapter 106: molecular biology and biochemistry of the coagulation factors and pathways of hemostasis. In: Lichtman MA, Beutler E, Kipps TJ, et al., editors. Williams hematology. New York: McGraw Hill Medical; 2006.
2. Majerus PW, Tollefsen DM. Blood coagulation and anticoagulant, thrombolytic, and antiplatelet drugs. In: Brunton LL, Lazo JS, Parker KL, editors. The pharmacologic basis of therapeutics, 11th ed. New York: McGraw-Hill; 2006. pp. 1475-1486.
3. Cranenburg EC, Schurgers LJ, Vermeer C. Vitamin K: the coagulation vitamin that became omnipotent. Thromb Haemost 2007; 98:120-125.
4. Pearson DA. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants. Nutr Clin Pract 2007; 22:517-544.
5. Franco V, PolanczykCA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. Am J Med 2004; 116:651-656.
6. Khan T, Wynne H, Wood P, et al. Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin. Br J Haematol 2004; 124:348-354.
7. Sconce E, Khan T, Mason J, et al. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb Haemost 2005; 93:872-875.
8. Schurgers LJ, Shearer MJ, Hamulyak K, et al. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood 2004; 104:2682-2689.
9. Reese AM, Farnett LE, Lyons RM, et al. Low-dose vitamin K to augment anticoagulation control. Pharmacotherapy 2005; 25:1746-1751.
10. Sconce E, Avery P, Wynne H, Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007; 109:2419-2423.
11. Ford SK, Misita CP, Shilliday BB, et al. Prospective study of supplemental vitamin K therapy in patients on oral anticoagulants with unstable International Normalized Ratios. J Thromb Thrombolysis 2007; 24:23-27.
12. Rombouts EK, Rosendaal FR, Van Der Meer FJ. Daily vitamin K supplementation improves anticoagulant stability. J Thromb Haemost 2007; 5:2043-2048.
13. Stafford DW, Roberts HR, Vermeer C. Vitamin K supplementation during oral anticoagulation: concerns. Blood 2007; 109:3607. [authorreply 3607-3608].
14. Spronk HM, Soute BA, Schurgers LJ, et al. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarintreated rats. J Vasc Res 2003; 40:531-537.
15. Koos R, Mahnken AH, Muhlenbruch G, et al. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am J Cardiol 2005; 96:747-749.
16. Holden RM, Sanfilippo AS, Hopman WM, et al. Warfarin and aortic valve calcification in hemodialysis patients. J Nephrol 2007; 20:417-422.
17. Moll S. Clinical practice of supplemental vitamin K therapy in patients on oral anticoagulants with unstable International Normalized Ratios: a questionnairebased study [abstract]. J Thromb Thrombolysis 2007; 25:97.